NCT04950582|SuspendedFDA Device
Study Stopped
temporary pause due to business priorities
Loading search results
Sponsor study identifier
observational
500
1 country
1
Study Start
June 4, 2021
Actual (reported)Primary Completion
June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a multi-center feasibility study to assess the in vitro function of the CloudCath Device that is being developed to derive clinically-relevant information from the optical characteristics of urine.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 4, 2021
Actual (reported)June 9, 2021
Actual (reported)July 6, 2021
Actual (reported)June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Spectral characteristics of urine specimens
A quantitative analysis of the spectral properties of the urine specimen using a proprietary algorithm that results in a quantitative CloudCath Turbidity Score (0-100, with higher values indicating more turbidity).
During the period of time that the patient is catheterized (expected to be up to ~1 week)
patients who are at high risk for developing a urinary tract infection (UTI).
Urine sample analysis for evidence of urinary tract infection
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
patients with indwelling urinary catheters
CloudCath Investigational Site
Guadalajara, Jalisco, Mexico
Ben Briggs, MD, PhD
University of California, San Francisco
First Submitted
June 9, 2021
First Posted
July 6, 2021
Study Start
June 4, 2021
Actual (reported)Primary Completion
June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Quick-Wee Versus Bladder Stimulation System to Collect Midstream Urine From Pre-continent Infants
The Effectiveness of a Bacteriophobic Coating on Urinary Catheters
Contact the study team to confirm eligibility.
Study Completion
June 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 21, 2023
Record last verified: 2023-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: